Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Atazanavir

An HIV protease inhibitor approved in the United States in 2003: it stops new virus particles from maturing and is used in combination with other antiretroviral medicines. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It is an azapeptide, designed as an analogue of the peptide chain that HIV protease cuts: it mimics the transition state in which the bond between a phenylalanine and a proline is broken.

AtazanavirGo to the active ingredient →
AtazanavirActive ingredientAtazanavirCat. No. P-A204-001CAS 198904-31-3
Atazanavir-d6Isotopically labelledAtazanavir-d6Cat. No. P-A204-010CAS 1092540-50-5

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.